118 related articles for article (PubMed ID: 27094350)
1. Evaluation of Endocrine Late Complications in Childhood Acute Lymphoblastic Leukemia Survivors: A Report of a Single-Center Experience and Review of the Literature.
Bayram C; Yaralı N; Fettah A; Demirel F; Tavil B; Kara A; Tunç B
Turk J Haematol; 2017 Mar; 34(1):40-45. PubMed ID: 27094350
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and Bone Minerals Status in the Long-term Survivors of Childhood Acute Lymphoblastic Leukemia.
Reisi N; Iravani P; Raeissi P; Kelishadi R
Int J Prev Med; 2015; 6():87. PubMed ID: 26445634
[TBL] [Abstract][Full Text] [Related]
3. Endocrine outcome in long-term survivors of childhood brain tumors.
Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
[TBL] [Abstract][Full Text] [Related]
4. [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia].
Skoczeń S; Tomasik P; Balwierz W; Surmiak M; Sztefko K; Galicka-Latała D
Przegl Lek; 2011; 68(9):592-6. PubMed ID: 22335007
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic Leukemia.
Schündeln MM; Hauffa PK; Munteanu M; Kiewert C; Unger N; Bauer JJ; Hauffa BP; Grasemann C
Front Pediatr; 2020; 8():509. PubMed ID: 32984219
[No Abstract] [Full Text] [Related]
6. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
[TBL] [Abstract][Full Text] [Related]
8. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
[TBL] [Abstract][Full Text] [Related]
9. Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience.
Mohapatra S; Bansal D; Bhalla AK; Verma Attri S; Sachdeva N; Trehan A; Marwaha RK
Pediatr Hematol Oncol; 2016 Mar; 33(2):136-49. PubMed ID: 26984439
[TBL] [Abstract][Full Text] [Related]
10. Late endocrine effects of childhood cancer.
Rose SR; Horne VE; Howell J; Lawson SA; Rutter MM; Trotman GE; Corathers SD
Nat Rev Endocrinol; 2016 Jun; 12(6):319-36. PubMed ID: 27032982
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life.
Schündeln MM; Hauffa PK; Bauer JJ; Temming P; Sauerwein W; Biewald E; Bornfeld N; Hauffa BP; Grasemann C
Pediatr Hematol Oncol; 2015; 32(7):455-66. PubMed ID: 26237585
[TBL] [Abstract][Full Text] [Related]
12. Late effects among long-term survivors of childhood acute leukemia in The Netherlands: a Dutch Childhood Leukemia Study Group Report.
van der Does-van den Berg A; de Vaan GA; van Weerden JF; Hählen K; van Weel-Sipman M; Veerman AJ
Pediatr Res; 1995 Nov; 38(5):802-7. PubMed ID: 8552452
[TBL] [Abstract][Full Text] [Related]
13. Late complications in childhood central nervous system tumour survivors.
Anderson NE
Curr Opin Neurol; 2003 Dec; 16(6):677-83. PubMed ID: 14624076
[TBL] [Abstract][Full Text] [Related]
14. [Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up].
Güemes Hidalgo M; Muñoz Calvo MT; Fuente Blanco L; Villalba Castaño C; Martos Moreno GA; Argente J
An Pediatr (Barc); 2014 Jun; 80(6):357-64. PubMed ID: 24103246
[TBL] [Abstract][Full Text] [Related]
15. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of osteopathologies in a single center cohort of survivors of childhood primary brain tumor.
Schündeln MM; Fritzemeier S; Goretzki SC; Hauffa PK; Munteanu M; Kiewert C; Hauffa BP; Fleischhack G; Tippelt S; Grasemann C
Front Pediatr; 2022; 10():913343. PubMed ID: 35923779
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
18. Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.
Karakaya P; Yılmaz S; Tüfekçi O; Kır M; Böber E; Irken G; Oren H
Turk J Haematol; 2013 Sep; 30(3):290-9. PubMed ID: 24385809
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
Thomas IH; Donohue JE; Ness KK; Dengel DR; Baker KS; Gurney JG
Cancer; 2008 Dec; 113(11):3248-56. PubMed ID: 18932250
[TBL] [Abstract][Full Text] [Related]
20. Evidence that children born at early term (37-38 6/7 weeks) are at increased risk for diabetes and obesity-related disorders.
Paz Levy D; Sheiner E; Wainstock T; Sergienko R; Landau D; Walfisch A
Am J Obstet Gynecol; 2017 Nov; 217(5):588.e1-588.e11. PubMed ID: 28729012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
